Director · Cue Biopharma, Inc. · Cue Biopharma, Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
1,626
Price
—
Executed
May 30, 2026
Disclosed
Jun 2, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
May 30 executedJun 2, 2026 disclosed
CUE · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Meehan Viola Mong filed this Form 4 reporting a grant or award of CUE on May 30, 2026. It became public on Jun 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Meehan Viola Mongcik:0002137444
Issuer
Cue Biopharma, Inc.cik:0001645460
Revision history · 0
No field has changed since this record was first ingested.
